Canaccord Genuity raises Apogee Therapeutics PT to $130 from $89, maintains Buy rating.

martes, 24 de marzo de 2026, 10:49 am ET1 min de lectura
APGE--

Canaccord Genuity raises Apogee Therapeutics PT to $130 from $89, maintains Buy rating.

Canaccord Genuity raises Apogee Therapeutics PT to $130 from $89, maintains Buy rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios